Wen Dang

机构：Shenyang Pharmaceutical University, University of Macau, Liaoning University of Traditional Chinese Medicine · ORCID：0000-0001-5554-9103

发表论文 41 篇 · 总被引 1469 次 · h-index 23

代表论文

• Risk factors of medical device‐related pressure injury in intensive care units (2021 · Journal of Clinical Nursing · 被引 73)
• 6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling (2018 · Antiviral Research · 被引 60)
• Cellular DNAJA3, a Novel VP1-Interacting Protein, Inhibits Foot-and-Mouth Disease Virus Replication by Inducing Lysosomal Degradation of VP1 and Attenuating Its Antagonistic Role in the Beta Interferon Signaling Pathway (2019 · Journal of Virology · 被引 55)
• Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response (2018 · Antimicrobial Agents and Chemotherapy · 被引 53)
• Peste des Petits Ruminants Virus Nucleocapsid Protein Inhibits Beta Interferon Production by Interacting with IRF3 To Block Its Activation (2019 · Journal of Virology · 被引 50)
• Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge (2022 · Asian Journal of Psychiatry · 被引 49)